Spinal device company Alphatec recorded total revenue of $169 million during the first quarter of 2025, according to a May 1 news release.
Here are five additional notes on the company’s first-quarter performance:
- The company’s surgical revenue totaled $152 million, driven by a 17% increase in procedural volume growth.
- Alphatec had a GAAP gross margin of 69% and a non-GAAP gross margin of 70%.
- The company had a GAAP net loss of $52 million.
- Alphatec’s gross profit was $116 million, up from $97.4 million in the first quarter of 2024.
- The company expects 2025 revenue to reach $734 million, up slightly from its last projection of $732 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
